INOUE BALLOON CATHETER

Catheter, Percutaneous (valvuloplasty)

FDA Premarket Approval P910054 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for modifications to the inoue balloon catheter which is indicated for percutaneous transvenous mitral commissurotomy in patients with hemodynamically significant mitral valvular stenosis resulting primarily from commissural fusion of the mitral valve cusps.

DeviceINOUE BALLOON CATHETER
Classification NameCatheter, Percutaneous (valvuloplasty)
Generic NameCatheter, Percutaneous (valvuloplasty)
ApplicantToray Industries (America), Inc.
Date Received2001-05-21
Decision Date2002-02-13
PMAP910054
SupplementS002
Product CodeMAD
Advisory CommitteeCardiovascular
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address Toray Industries (America), Inc. 461 Fifth Avenue, 9th Floor new York, NY 10017

Supplemental Filings

Supplement NumberDateSupplement Type
P910054Original Filing
S008 2021-08-13 30-day Notice
S007 2020-03-04 30-day Notice
S006 2018-09-04 30-day Notice
S005 2011-04-19 30-day Notice
S004 2006-11-15 135 Review Track For 30-day Notice
S003
S002 2001-05-21 Normal 180 Day Track
S001 1995-05-22 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.